Description:
This is a single arm study to evaluate the safety and biodistribution of 89Zr-labeled NY108 (89Zr-NY108) PET Imaging in patients with Prostate cancer.
Sponsor:
Government Study Link:
ClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468